New report analyzes 1,350+ precision medicine deals from 2019-2026, revealing market trends and deal structures.

ResearchAndMarkets.com released a comprehensive report covering over 1,350 precision medicine collaboration and licensing deals from 2019 to 2026. The report offers detailed insights into deal structures, financial terms, and partnership strategies, highlighting how data, diagnostics, and targeted therapies integrate in precision medicine. It serves as a key resource for companies to benchmark deals, prepare negotiations, and understand market standards with access to contract-level details. This transparency aids in valuing and structuring deals in a complex, data-driven therapeutic landscape.